These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 12204057)

  • 1. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
    Korshunov A; Shishkina L; Golanov A
    Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proliferative markers of meningiomas: immunohistochemical analysis and prognostic value].
    Korshunov AG; Shishkina LV; Golanov AV
    Arkh Patol; 2002; 64(1):29-33. PubMed ID: 11889696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome.
    Korshunov A; Shishkina L; Golanov A
    Int J Cancer; 2003 May; 104(6):728-34. PubMed ID: 12640680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
    Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
    J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitosin, a novel marker of cell proliferation and early recurrence in intracranial meningiomas.
    Konstantinidou AE; Korkolopoulou P; Kavantzas N; Mahera H; Thymara I; Kotsiakis X; Perdiki M; Patsouris E; Davaris P
    Histol Histopathol; 2003 Jan; 18(1):67-74. PubMed ID: 12507285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical evaluation of intracranial recurrent meningiomas: correlation of topoisomerase II alpha expression and cell proliferative potential].
    Tanaka M; Kubo O; Tajika Y; Takahashi T; Suzuki S; Takakura K
    No To Shinkei; 1999 Dec; 51(12):1033-9. PubMed ID: 10654298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
    Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
    Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas.
    Korshunov A; Golanov A
    Arch Pathol Lab Med; 2001 Jul; 125(7):892-8. PubMed ID: 11419973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA topoisomerase IIalpha expression correlates with cell proliferation but not with recurrence in intracranial meningiomas.
    Konstantinidou AE; Patsouris E; Korkolopoulou P; Kavantzas N; Mahera H; Davaris P
    Histopathology; 2001 Oct; 39(4):402-8. PubMed ID: 11683942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery.
    Winther TL; Torp SH
    PLoS One; 2017; 12(3):e0172316. PubMed ID: 28301542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.
    Prat-Acín R; Guarín-Corredor MJ; Galeano-Senabre I; Ayuso-Sacido A; Vera-Sempere F
    J Clin Neurosci; 2021 Apr; 86():32-37. PubMed ID: 33775343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase II alpha as a reliable proliferation marker in meningiomas.
    Roessler K; Gatterbauer B; Kitz K
    Neurol Res; 2002 Apr; 24(3):241-3. PubMed ID: 11958416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
    Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
    Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.
    Ho DM; Hsu CY; Ting LT; Chiang H
    Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma.
    Choi Y; Lim DH; Yu JI; Jo K; Nam DH; Seol HJ; Lee JI; Kong DS; Suh YL; Nam H
    Am J Clin Oncol; 2018 Jan; 41(1):18-23. PubMed ID: 26270441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 immunoreactivity in meningiomas.
    Milenković S; Marinkovic T; Jovanovic MB; Djuricic S; Berisavac II; Berisavac I
    Cell Mol Neurobiol; 2008 Sep; 28(6):907-13. PubMed ID: 18379871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study.
    Takeuchi H; Kubota T; Kabuto M; Kitai R; Nozaki J; Yamashita J
    Surg Neurol; 1997 Nov; 48(5):501-6. PubMed ID: 9352816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclin A and topoisomerase IIalpha of oligodendrogliomas is correlated with tumour grade, MIB-1 labelling index and survival.
    Park SH; Suh YL
    Histopathology; 2003 Apr; 42(4):395-402. PubMed ID: 12653952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas.
    Lin YW; Tai SH; Huang YH; Chang CC; Juan WS; Chao LC; Wen MJ; Hung YC; Lee EJ
    Cytometry B Clin Cytom; 2015; 88(5):312-9. PubMed ID: 25408130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.